Tatva Chintan Pharma Chem Limited (NSE:TATVA)

India · Delayed Price · Currency is INR

1,338.00

-14.00 (-1.04%)

May 11, 2026, 1:19 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Specialty Chemical Business	3.83B	3.94B	4.24B	4.34B	3.00B
Specialty Chemical Business Growth	-2.74%	-7.11%	-2.31%	44.38%	14.10%
Total	3.83B	3.94B	4.24B	4.34B	3.00B
Total Growth	-2.74%	-7.11%	-2.31%	44.38%	14.10%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Overseas	2.35B	2.77B	3.04B	3.40B	2.13B
Overseas Growth	-14.95%	-9.00%	-10.64%	60.04%	5.31%
India	1.44B	1.14B	1.17B	908.27M	841.16M
India Growth	27.10%	-2.59%	28.44%	7.98%	51.11%
Total	3.80B	3.90B	4.21B	4.31B	2.97B
Total Growth	-2.71%	-7.22%	-2.41%	45.29%	15.20%

Source: S&P Global Market Intelligence.